Efficacy of azithromycin combined with intravenous immunoglobulin in the treatment of refractory mycoplasma pneumoniae pneumonia in children: a meta-analysis
Abstract Background The incidence of refractory Mycoplasma pneumoniae pneumonia (RMPP) in children is increasing, posing a serious threat to life safety. Intravenous immunoglobulin (IVIG) has demonstrated the ability to modulate the immune system and has shown the potential to treat RMPP. This study...
Saved in:
Main Authors: | Yuan-yuan Shen (Author), Zi-qiang Feng (Author), Zhong-ping Wang (Author), Xue-qin Wang (Author), Cheng Luo (Author), Qing-zhong Liu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correlation between Mycoplasma pneumoniae drug resistance and clinical characteristics in bronchoalveolar lavage fluid of children with refractory Mycoplasma pneumoniae pneumonia
by: Xiao-Wen Zhan, et al.
Published: (2022) -
Consideration in treatment decisions for refractory Mycoplasma pneumoniae pneumonia
by: Hye-Kyung Cho
Published: (2021) -
Development of a Nomogram for Predicting Refractory Mycoplasma pneumoniae Pneumonia in Children
by: Fangfang Shen, et al.
Published: (2022) -
Construction of a Nomogram for Identifying Refractory Mycoplasma pneumoniae Pneumonia Among Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children
by: Xie Q, et al.
Published: (2022) -
Acetylcysteine and budesonide for the treatment of refractory Mycoplasma pneumoniae pneumonia in children: a clinical observation
by: Yanli Wang, et al.
Published: (2023)